EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study

Salvatore Rotundo, Alessandro Russo, Rocco Morena, Eugenio Garofalo, Helen Linda Morrone, Giuseppe Mazza, Giuseppe Neri, Nadia Marascio, Andrea Bruni, Giovanni Matera, Angela Quirino, Francesca Serapide

Journal of Antimicrobial Chemotherapy · 02.02.2026 · 81 (3)

DOI: 10.1093/jac/dkag056 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 17.02.2026. Verfasst von Salvatore Rotundo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, 'San Giovanni di Dio' Hospital, Crotone, Italy. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Anti-Bacterial Agents, Bacteremia, Gram-Negative Bacteria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study assessed the real-world clinical impact of rapid antimicrobial susceptibility testing (RAST) compared with conventional susceptibility testing (AST) in critically ill patients with Gram-negative bloodstream infections (GNB BSIs), focusing on early optimization of therapy and clinical outcomes in a high multidrug-resistant (MDR) setting.

Methods

We conducted a retrospective, observational study including adult patients with GNB BSIs who were stratified according to the susceptibility testing strategy used (RAST or conventional AST). The primary outcome was 30-day all-cause mortality. Secondary outcomes included administration of early active antimicrobial therapy, clinical failure and length of both intensive care unit (ICU) and hospital stay.

Results

A total of 133 patients were included (RAST: 37; AST: 96). Thirty-day mortality was observed in 4/37 patients (10.8%) in the RAST group and in 30/96 (31.3%) in the AST group (P = 0.015). Early active therapy was administered to 32/37 (86.5%) RAST patients versus 44/96 (45.8%) in the AST group (P < 0.001). Clinical failure occurred in 0/37 RAST patients versus 20/96 (20.8%) AST patients (P = 0.003). Mean ICU stay was 30.3 ± 22.9 days (RAST) versus 36.9 ± 25.6 days (AST), P = 0.17. In Cox regression analysis, RAST-guided management (HR = 0.16, 95% CI 0.04–0.62) and early active therapy (HR = 0.51, 95% CI 0.19–0.94) were independently associated with survival.

Conclusions

RAST may represent a valuable tool to optimize antimicrobial therapy in critically ill patients with GNB BSIs, particularly considering the increasing prevalence of MDR pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gram-Negative Bacterial InfectionsAnti-Bacterial AgentsBacteremiaGram-Negative BacteriaHumansRetrospective StudiesFemaleCritical IllnessMicrobial Sensitivity TestsMaleAgedMiddle AgedTreatment OutcomeSurvival AnalysisLength of StayIntensive Care UnitsAged, 80 and over

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Infectious Diseases Unit, 'San Giovanni di Dio' Hospital, Crotone, Italy.
  • Infectious and Tropical Disease Unit, 'Renato Dulbecco' University Hospital, Catanzaro, Italy.
  • Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
  • Intensive Care Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.
  • Clinical Microbiology Unit, 'Renato Dulbecco' University Hospital, Catanzaro, Italy.
  • Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.

Zitieren

APA

Rotundo, S., Russo, A., Morena, R., Garofalo, E., Morrone, H. L., Mazza, G., Neri, G., Marascio, N., Bruni, A., Matera, G., Quirino, A., & Serapide, F. (2026). Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study. Journal of Antimicrobial Chemotherapy, 81(3). https://doi.org/10.1093/jac/dkag056

Vancouver

Rotundo S, Russo A, Morena R, Garofalo E, Morrone HL, Mazza G, et al. Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2026;81(3). doi:10.1093/jac/dkag056

BibTeX
@article{Rotundo2026,
  author = {Rotundo, Salvatore and Russo, Alessandro and Morena, Rocco and Garofalo, Eugenio and Morrone, Helen Linda and Mazza, Giuseppe and Neri, Giuseppe and Marascio, Nadia and Bruni, Andrea and Matera, Giovanni and Quirino, Angela and Serapide, Francesca},
  title = {Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {3},
  doi = {10.1093/jac/dkag056}
}
Kostenlos starten →